These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7387335)

  • 1. beta-Endorphin and schizophrenia.
    Berger PA; Watson SJ; Akil H; Elliott GR; Rubin RT; Pfefferbaum A; Davis KL; Barchas JD; Li CH
    Arch Gen Psychiatry; 1980 Jun; 37(6):635-40. PubMed ID: 7387335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
    Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
    Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic studies of beta-endorphin in psychopathology.
    Berger PA; Barchas JD
    Psychiatr Clin North Am; 1983 Sep; 6(3):377-91. PubMed ID: 6316299
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist.
    Naber D; Münch U; Wissmann J; Grosse R; Ritt R; Welter D
    Acta Psychiatr Scand; 1983 Apr; 67(4):265-71. PubMed ID: 6305111
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Volavka J; Hui KS; Anderson B; Nemes Z; O'Donnell J; Lajtha A
    Psychiatry Res; 1983 Dec; 10(4):243-52. PubMed ID: 6583715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.
    Lehmann H; Nair NP; Kline NS
    Am J Psychiatry; 1979 Jun; 136(6):762-6. PubMed ID: 220889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Endorphin studies in psychiatric patients.
    Gorelick DA; Catlin DH; Gerner RH
    Mod Probl Pharmacopsychiatry; 1981; 17():236-45. PubMed ID: 6276728
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of beta-endorphin in psychiatric patients.
    Berger PA; Barchas JD
    Ann N Y Acad Sci; 1982; 398():448-59. PubMed ID: 6297364
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients.
    Gerner RH; Catlin DH; Gorelick DA; Hui KK; Li CH
    Arch Gen Psychiatry; 1980 Jun; 37(6):642-7. PubMed ID: 7387336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
    Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
    Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients.
    Schulz SC; van Kammen DP; Pickar D; Cohen MR; Naber D
    Psychiatry Res; 1982 Oct; 7(2):171-8. PubMed ID: 6292981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 14. Human EEG response to beta-endorphin.
    Pfefferbaum A; Berger PA; Elliott GR; Tinklenberg JR; Kopell BS; Barchas JD; Li CH
    Psychiatry Res; 1979 Jul; 1(1):83-8. PubMed ID: 298341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
    Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
    Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Kissling W; Dirlich G; Herz A
    Mod Probl Pharmacopsychiatry; 1981; 17():279-86. PubMed ID: 7329421
    [No Abstract]   [Full Text] [Related]  

  • 17. Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report.
    Tamminga CA; Tighe PJ; Chase TN; DeFraites EG; Schaffer MH
    Arch Gen Psychiatry; 1981 Feb; 38(2):167-8. PubMed ID: 7212942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Endorphin administration to acute schizophrenic patients: a double blind study.
    Pethö B; Gráf L; Karczag I; Borvendég J; Bitter I; Barna I; Hermann I; Tolna J; Baraczka K
    Ann N Y Acad Sci; 1982; 398():460-9. PubMed ID: 6297365
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):290-8. PubMed ID: 7003611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.